Next |
home / stock / embi / embi message board
Subject | By | Source | When |
---|---|---|---|
Is this too late to buy this stock? | HoanTuong | investorshub | 01/15/2021 4:15:08 PM |
This stock you can go long | Dutchpaul1 | investorshub | 01/14/2021 12:46:57 PM |
Grabbed a starter on $EMBI this morning. | PepsiMan | investorshub | 01/13/2021 5:26:11 PM |
$EMBI - Emerald Bioscience Inc Forecast - CNNMoney.com | Dutchpaul1 | investorshub | 01/13/2021 12:29:53 PM |
Yahoo Finance...look $EMBI | Dutchpaul1 | investorshub | 01/08/2021 10:56:28 PM |
Emerald Bioscience Creates Unique Path to Prevent Blindness | IHuser | investorshub | 01/07/2021 10:14:43 PM |
News Emerald Bioscience to Present at the KCSA Cannabis | IHuser | investorshub | 01/07/2021 10:02:56 PM |
News Emerald Bioscience to Present at the KCSA Cannabis | IHuser | investorshub | 01/07/2021 10:02:55 PM |
Company Profile | IHuser | investorshub | 01/07/2021 10:01:28 PM |
Where did you see the patent info? I have | CAPTDASH | investorshub | 01/07/2021 4:51:47 PM |
new shell...mj blindness eye surgery...patented...let's get rich..$1.00PT..$EMBI | IHuser | investorshub | 01/05/2021 6:51:33 PM |
I hope so. I loaded up on it. | CAPTDASH | investorshub | 12/30/2020 5:34:20 AM |
Is this good to buy anyone !Merry Xmax | HoanTuong | investorshub | 12/26/2020 6:48:08 PM |
^^^^^^^^^^ 06 ON DECK ^^^^^^^^^^^^^ $EMBI WEEEEEEEEEEEEEEE | 1plus1 | investorshub | 12/18/2020 8:15:41 PM |
i see bunch of smacks going thru | 1plus1 | investorshub | 12/18/2020 7:39:30 PM |
nice been holding for a while >> reason | 1plus1 | investorshub | 12/18/2020 7:38:35 PM |
I had to buy way over the ask | Dutchpaul1 | investorshub | 12/18/2020 7:37:24 PM |
When you try to nuy, the ask doesnt | Dutchpaul1 | investorshub | 12/18/2020 7:31:47 PM |
maybe because cnn money | Dutchpaul1 | investorshub | 12/18/2020 7:14:04 PM |
why are we up ?? | 1plus1 | investorshub | 12/18/2020 7:09:42 PM |
News, Short Squeeze, Breakout and More Instantly...
Emerald Bioscience Inc Company Name:
EMBI Stock Symbol:
OTCMKTS Market:
San Diego, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with s...
San Diego, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with s...
San Diego, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with si...